Vivos Therapeutics, Inc. (VVOS)

Nasdaq: VVOS · Surgical & Medical Instruments & Apparatus · Littleton, CO · filing with the SEC since 2017

Grade3.0

◀ Past 1.9● Present 3.4▶ Future 3.7

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Report filed	Apr 15, 2026	Mar 31, 2025	Mar 28, 2024	Mar 30, 2023	Mar 31, 2022	Mar 25, 2021	·
Revenue	17,443,000	15,031,000	13,801,000	16,024,000	16,885,000	13,066,000^r	11,393,277
For lenders
Interest and dividend income	·	·	·	·	117,000	79,000^r	21,133
Cost of revenue	6,901,000	6,012,000	5,530,000	6,005,000	4,281,000	2,653,000^r	2,736,034
Gross profit	10,542,000	9,019,000	8,271,000	10,019,000	12,604,000	10,413,000^r	8,657,243
Research and development	100,000	100,000	100,000	200,000	200,000	·	·
Sales and marketing	1,400,000	1,731,000	2,467,000	5,340,000	5,551,000	2,314,000^r	2,310,743
General and administrative	27,727,000	17,878,000	22,479,000	29,041,000	25,791,000	16,090,000^r	16,172,505
Total operating expenses	30,436,000	20,190,000	25,567,000	35,050,000	32,986,000	22,453,000^r	19,234,476
Operating income	-19,894,000	-11,171,000	-17,296,000	-25,031,000	-20,382,000	-12,040,000^r	-10,577,233
Interest expense	1,400,000	·	·	·	14,000	96,000^r	137,876
Other income (expense), net	-1,481,000	-110,000	-212,000	-190,000	-9,000	·	·
Income before income taxes	-21,230,000	-11,136,000	-13,583,000	-23,845,000	-20,288,000	-12,057,000^r	-10,754,319
Net income including non-controlling interests	-21,230,000	-11,136,000	·	·	·	·	·
Net income to non-controlling interests	-60,000	·	·	·	·	·	·
Net income	-21,170,000	-11,136,000	-13,583,000	-23,845,000	-20,288,000	-12,057,000^r	-10,754,319
Net income to common shareholders	-21,230,000	-11,136,000	-13,583,000	-23,845,000	-20,288,000	-17,988,000^r	-11,754,319
Earnings per share, basic	-2.07	-2.22	-11.14	-25.90^r	-0.96	·	·
Earnings per share, diluted	-2.07	-2.22	-11.14	-25.90	·	·	·
Earnings per share, basic and diluted	·	·	·	·	-0.96	-1.40	-0.95
Weighted average shares, basic	10,273,881	5,019,886	1,219,381	920,592^r	21,233,485,000	·	·
Weighted average shares, diluted	10,273,881	5,019,886	1,219,381	920,592	·	·	·
Weighted average shares, basic and diluted	·	·	·	·	21,233,000	12,869,000^r	12,331,280

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax

Interest and dividend income what its loans and securities earnedus-gaap:InterestIncomeOperating

Cost of revenue what it cost to make or buy what it sold

us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
us-gaap:CostOfRevenue

Gross profit revenue less the cost of what it soldus-gaap:GrossProfit

Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense

Sales and marketing the cost of finding and serving customersus-gaap:SellingAndMarketingExpense

General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense

Total operating expenses the running costs togetherus-gaap:OperatingExpenses

Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss

Interest expense what its borrowing costus-gaap:InterestExpense

Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense

Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss

Net income to non-controlling interests the share that belongs to minority holdersus-gaap:NetIncomeLossAttributableToNoncontrollingInterest

Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss

Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic

Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic

Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted

Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted

Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic

Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted

SI Assistanton VVOS · research, not advice